DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF EZETIMIBE VERSUS ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOMTAHEN M.; FARSAD F.; ABAS M.; MOMTAHAN S.; KAZAZI A.S.A.D.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN HEART JOURNAL Year:2007 | Volume:8 | Issue:1 Page(s): 33-37

Download Full-Text

View:

289

Download:

121

Cites:

Information Journal Paper

Title

DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF EZETIMIBE VERSUS ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

Author(s)

Keywords

EZETIMIBE

ATORVASTATIN

HYPERCHOLESTEROLEMIA

Abstract

Objective- This randomized, double blind trial was designed to compare the efficacy and safety of ezetimibe, a new cholesterol-lowering agent with atorvastatin (Lipitor), a potent cholesterol inhibitor derivative.Method- Between September 2004 and March 2005, a total of 120 hyperlipidemic patients, aged 28-80 years, were randomized to receive ezetimibe 10 mg or atorvastatin 10 mg orally daily for 8 weeks after a 4-week washout phase and diet on NCEP step n. Mean changes of serum lipoproteins after 4 and 8 weeks of drug therapy were measured and compared in both groups of patients.Results- Ezetimibe reduced LDLc and total cholesterol by a mean of 27% and 16% compared with 32% and 24% for atorvastatin, respectively. The difference was not statistically significant. Conclusion- Ezetimibe and atorvastatin both reduced LDLc and TC with no statistically significant difference.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

MOMTAHEN, M., FARSAD, F., ABAS, M., MOMTAHAN, S., & KAZAZI, A.S.A.D.. (2007). DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF EZETIMIBE VERSUS ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA. IRANIAN HEART JOURNAL (IHJ), 8(1), 33-37. SID. https://sid.ir/paper/279491/en

Vancouver: Copy

MOMTAHEN M., FARSAD F., ABAS M., MOMTAHAN S., KAZAZI A.S.A.D.. DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF EZETIMIBE VERSUS ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA. IRANIAN HEART JOURNAL (IHJ)[Internet]. 2007;8(1):33-37. Available from: https://sid.ir/paper/279491/en

IEEE: Copy

M. MOMTAHEN, F. FARSAD, M. ABAS, S. MOMTAHAN, and A.S.A.D. KAZAZI, “DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF EZETIMIBE VERSUS ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA,” IRANIAN HEART JOURNAL (IHJ), vol. 8, no. 1, pp. 33–37, 2007, [Online]. Available: https://sid.ir/paper/279491/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops